Article Figures & Data
Tables
Parameters n (%) Age 0-29 days 260 (12.3) 1-12 months 1006 (47.3) 1-3 years 415 (19.5) 3-6 years 217 (10.2) >6 years 228 (10.7) Total 2126 (100) Source of referral Main PEC 1901 (89.4) PEC satellites 194 (9.1) Other hospitals 31 (1.5) Values are presented as numbers and percentages (%). PEC: pediatric emergency center
Parameters n (%) Diagnosis Rule out sepsis 789 (37.1) Urinary tract infection 531 (25) Lower respiratory tract infection 198 (9.3) Dermatological conditions 93 (4.4) Hematological and oncological 90 (4.2) Abscess including dental abscess 78 (3.7) Neurological conditions 70 (3.3) GIT including salmonella infection 51 (2.4) ENT (AOM, pharyngitis) infections 50 (2.4) Lymphadenitis and infected cysts 46 (2.2) Ophthalmological conditions 22 (1.0) musculoskeletal and joints 5 (0.2) Others 103 (4.8) Total 2126 (100) Duration of symptoms (days) 1-2 1533 (73.0) 3-4 366 (17.0) 5-10 193 (9.0) ≥11 19 (1.0) Total 2111 (100) Primary co-morbidities Neurological and metabolic 171 (30.0) Congenital anomalies 151 (27.0) Hematology, oncology, and allergy 144 (26.0) Renal and urologic disorders 46 (8.0) Prematurity-related disorders 22 (4.0) Others 28 (5.0) Total 562 (100) Length of stay in OPT unit (days) n (%) Total no. of days 1 1136 (54.5) 1136 2 366 (17.6) 732 3 533 (25.6) 1599 4 49 (2.3) 196 Grand total (days) 3663 Values are presented as numbers and percentages (%). GIT: gastro intestinal tract, ENT: ear, nose, and throat, AOM: acute otitis media, OPT: outpatient parenteral therapy
- Table 3
- Laboratory workup prior treatment initiation in the outpatient parenteral therapy unit.
Parameters n Results Cultures type, no growth Blood 2038 1913 (94.0) Urine 1675 1041 (62.2) CSF 717 716 (99.9) Others 89 51 (57.3) High blood WBC Neonates 280 19 (6.8) Infants 1007 378 (37.5) Older 1088 361 (33.2) Low blood WBC Neonates 280 20 (7.1) Infants 1007 5 (0.5) Older 1088 47 (4.3) Uncentrifuged urine WBC, high (>10/HPF) 1312 595 (45.3) Values are presented as numbers and precentages (%). WBC: white blood cell count, CSF: cerebrospinal fluid, HPF: high power field
Parameters n (%) Antibiotics in the observation areas Cephalosporins (ceftriaxone/cefotaxime/cefepime, cefuroxime) 1516 (75.0) Amikacin/gentamycin 285 (14.0) Clindamycin 170 (8.0) Other antibiotics 83 (4.0) IV antibiotics in OPT unit Cephalosporins (ceftriaxone/cefotaxime/cefepime, cefuroxime) 1556 (75.0) Amikacin/gentamycin 300 (14.0) Clindamycin 164 (8.0) Other antibiotics 52 (3.0) Duration of stay in observation areas (hours) ≤24 2026 (96.5) >24-48 33 (1.6) >48 6 (0.3) Duration of intravenous treatment in OPT unit (days) ≤2 1403 (68.0) 3-4 489 (24.0) 5-6 130 (6.0) ≥7 27 (1.0) Total duration of IV and oral treatment in OPT unit (days) ≤2 1136 (55.0) 3-4 366 (18.0) 5-6 532 (26.0) 7-8 49 (2.0) Values are presented as numbers and percentages (%). OPT: outpatient parental therapy, IV: intravenous
Parameters Age P-values ≤3 months >3 months Total Total number 739 (34.8) 1387 (65.2) 2126 (100) Cure rate 735 (99.5) 1377 (99.3) 2112 (99.3) 0.626 Vascular access complications rate 114 (15.4) 335 (24.2) 449 (21.1) 0.001 Values are presented as numbers and percentages (%). P-value significance of <0.05.